Health News

DSPE Regulatory Update: Acceptance Of The European Medicines Agency Submission For An Atypical Antipsychotic Agent Lurasidone

Date: Oct-27-2012
Dainippon Sumitomo Pharma Europe Ltd ("DSPE") (Headquarters: London, UK) today announced that the European Medicines Agency (EMA) has confirmed that the Marketing Authorisation Application (MAA) for lurasidone hydrochloride, an atypical antipsychotic investigational medicine for the treatment of schizophrenia, is valid. The MAA was filed by Takeda Global Research & Development Centre (Europe). Dainippon Sumitomo Pharma Co., Ltd ("DSP") discovered and developed lurasidone...

Models Developed From The PLCO May Help Identify At-Risk Patients For Adverse Smoking Outcomes

Date: Oct-26-2012
Risk prediction models developed from an ancillary study of the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO) may be useful in the public health sector for identifying individuals who are at risk for adverse smoking outcomes, such as relapse among former smokers and continued smoking among current smokers, and those who may benefit from relapse prevention and smoking cessation interventions according to a study published October 26 in the Journal of the National Cancer Institute...

High European Mortality Rates Due to Sepsis Care

Date: Oct-26-2012
There are significant differences between the way the United States and Europe take care of patients with severe sepsis and septic shock, according to a study in The Lancet Infectious Diseases. Severe sepsis is a potentially fatal illness which results from an over-reaction of the immune system to an infection, which may progress into septic shock. The body's essential organs then become disrupted and a hazardous drop in blood pressure is seen. Each year, there are about 30,000 cases of severe sepsis in the UK...

Autism Early Intervention Can Help Regulate Brain Activity In Kids

Date: Oct-26-2012
A new type of early intervention therapy called Early Start Denver Model (ESDM) is effective for boosting language skills and cognitive thinking in autistic children as young as 18 months old. It can also help their social skills, decrease their symptoms of autism, and push their brain activity to work in a "normal" manner , according to a study published in theJournal of the American Academy of Child & Adolescent Psychiatry This is the first study of its kind to reveal that early intervention of autism can help "normalize" happenings in the brain...

Do We Have A European Tobacco Scandal?

Date: Oct-26-2012
Why is the European Union's (EU's) revised Tobacco Products Directive so close to stalling - people are beginning to ask. Some even wonder whose interest the EU Commission is promoting, authors in a Comment in The Lancet wrote today. The Tobacco Directive, which everybody expected would greatly restrict how tobacco companies could promote cigarettes and smokeless tobacco, including the prohibition of electronic cigarettes, seems to be on a never-ending road of permanent delays...

Gene Associated With Inflammation In The Aorta Could Lead To Abdominal Aortic Aneurysm

Date: Oct-26-2012
A gene that contributes to cancer and cardiovascular development may be the cause of swelling in the most common type of aortic aneurysm, and could be the key to treatment. This new study, published in Arteriosclerosis, Thrombosis, and Vascular Biology, is the first of its kind to show Notch 1 signaling is triggered in abdominal aortic aneurysmal tissue in humans and mice. The largest blood vessel in the body is the aorta. An abdominal aortic aneurysm (AAA), the most common form of aortic aneurysms, happen when the weakened aortic wall enlarges in the abdominal part of the vessel...

Sneak A Peek At The Agenda Of The Third Annual Health 2.0 Europe Conference In Berlin On Nov 6-7, 2012

Date: Oct-26-2012
Healthcare is changing profoundly due to new web and mobile applications. The conference Health 2.0 Europe addresses recent developments in this emerging field. The 2012 edition features exciting live technology demos and panels dedicated to answering the most urgent questions in health care. The Health 2...

Advances And Progress In Drug Design Conference, 18-19 February 2013, London

Date: Oct-26-2012
SMi is proud to present their 12th annual conference on Drug Design. This unique conference will provide an unparalleled opportunity for debate and problem solving of key challenges currently facing the field, allowing attendees to discuss progress in the area and exchange ideas moving forward, ensuring a truly comprehensive treatment of the most important issues...

Hydration Based On Ventricular Pressure Is Effective In Reducing Kidney Damage In Patients Undergoing Cardiac Catheterization

Date: Oct-26-2012
Results of the POSEIDON trial presented at TCT 2012 A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine...

Low Responsiveness To Clopidogrel Predicts Stent Thrombosis, Heart Attack: 1-Year Results Of ADAPT-DES Presented At TCT 2012

Date: Oct-26-2012
Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are more likely to have blood clots form on the stent and suffer a possible heart attack; conversely, patients with higher levels of platelet inhibition are at greater risk for bleeding complications. One-year results of the ADAPT-DES study were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine...